BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 10712684)

  • 1. Anaerobic nitrate reductase (narGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient mice.
    Weber I; Fritz C; Ruttkowski S; Kreft A; Bange FC
    Mol Microbiol; 2000 Mar; 35(5):1017-25. PubMed ID: 10712684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dependence of Mycobacterium bovis BCG on anaerobic nitrate reductase for persistence is tissue specific.
    Fritz C; Maass S; Kreft A; Bange FC
    Infect Immun; 2002 Jan; 70(1):286-91. PubMed ID: 11748194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphic nucleotide within the promoter of nitrate reductase (NarGHJI) is specific for Mycobacterium tuberculosis.
    Stermann M; Bohrssen A; Diephaus C; Maass S; Bange FC
    J Clin Microbiol; 2003 Jul; 41(7):3252-9. PubMed ID: 12843072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in nitrate reduction between Mycobacterium tuberculosis and Mycobacterium bovis are due to differential expression of both narGHJI and narK2.
    Sohaskey CD; Modesti L
    FEMS Microbiol Lett; 2009 Jan; 290(2):129-34. PubMed ID: 19076631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of narK2X and narGHJI in hypoxic upregulation of nitrate reduction by Mycobacterium tuberculosis.
    Sohaskey CD; Wayne LG
    J Bacteriol; 2003 Dec; 185(24):7247-56. PubMed ID: 14645286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A promoter mutation causes differential nitrate reductase activity of Mycobacterium tuberculosis and Mycobacterium bovis.
    Stermann M; Sedlacek L; Maass S; Bange FC
    J Bacteriol; 2004 May; 186(9):2856-61. PubMed ID: 15090527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-nucleotide mutation in the -10 promoter region inactivates the narK2X promoter in Mycobacterium bovis and Mycobacterium bovis BCG and has an application in diagnosis.
    Chauhan S; Singh A; Tyagi JS
    FEMS Microbiol Lett; 2010 Feb; 303(2):190-6. PubMed ID: 20041953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti.
    Pym AS; Brodin P; Brosch R; Huerre M; Cole ST
    Mol Microbiol; 2002 Nov; 46(3):709-17. PubMed ID: 12410828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrate reductase activity of Mycobacterium tuberculosis and Mycobacterium bovis in the presence of electron donors.
    Escoto ML; de Kantor IN
    J Clin Microbiol; 1978 Jun; 7(6):601-2. PubMed ID: 97306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis.
    Mahairas GG; Sabo PJ; Hickey MJ; Singh DC; Stover CK
    J Bacteriol; 1996 Mar; 178(5):1274-82. PubMed ID: 8631702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of the nitrate reductase NarGHJI, the nitrite reductase NirBD and the response regulator GlnR in nitrate assimilation of Mycobacterium tuberculosis.
    Malm S; Tiffert Y; Micklinghoff J; Schultze S; Joost I; Weber I; Horst S; Ackermann B; Schmidt M; Wohlleben W; Ehlers S; Geffers R; Reuther J; Bange FC
    Microbiology (Reading); 2009 Apr; 155(Pt 4):1332-1339. PubMed ID: 19332834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular evolutionary history of tubercle bacilli assessed by study of the polymorphic nucleotide within the nitrate reductase (narGHJI) operon promoter.
    Goh KS; Rastogi N; Berchel M; Huard RC; Sola C
    J Clin Microbiol; 2005 Aug; 43(8):4010-4. PubMed ID: 16081943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid testing for nitrate reductase activity of Mycobacterium tuberculosis grown in an automated culture system.
    Meyer A; Sedlacek L; Bange FC
    Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):444-6. PubMed ID: 12827528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis bacillus Calmette-GuĂ©rin, and Mycobacterium tuberculosis H37Rv by allelic exchange.
    Pavelka MS; Jacobs WR
    J Bacteriol; 1999 Aug; 181(16):4780-9. PubMed ID: 10438745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue.
    Hsu T; Hingley-Wilson SM; Chen B; Chen M; Dai AZ; Morin PM; Marks CB; Padiyar J; Goulding C; Gingery M; Eisenberg D; Russell RG; Derrick SC; Collins FM; Morris SL; King CH; Jacobs WR
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12420-5. PubMed ID: 14557547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphisms that cause structural changes in the cyclic AMP receptor protein transcriptional regulator of the tuberculosis vaccine strain Mycobacterium bovis BCG alter global gene expression without attenuating growth.
    Hunt DM; Saldanha JW; Brennan JF; Benjamin P; Strom M; Cole JA; Spreadbury CL; Buxton RS
    Infect Immun; 2008 May; 76(5):2227-34. PubMed ID: 18332206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis.
    Hondalus MK; Bardarov S; Russell R; Chan J; Jacobs WR; Bloom BR
    Infect Immun; 2000 May; 68(5):2888-98. PubMed ID: 10768986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phylogenomics of Mycobacterium Nitrate Reductase Operon.
    Huang Q; Abdalla AE; Xie J
    Curr Microbiol; 2015 Jul; 71(1):121-8. PubMed ID: 25980349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity.
    North RJ; Izzo AA
    J Exp Med; 1993 Jun; 177(6):1723-33. PubMed ID: 8496688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.